T here is growing evidence that essential hypertension is commonly neurogenic [1] [2] [3] [4] and is initiated and sustained by overactivity of the sympathetic nervous system. This increase in sympathetic nerve activity (SNA) has been demonstrated by indirect measures such as spillover of norepinephrine in human hypertensive patients, 5, 6 direct recordings of muscle SNA in humans, 1, 2, 6, 7 and direct recordings of primarily renal SNA (RSNA) in animal models of hypertension. [8] [9] [10] [11] [12] It is also known that there is differential control of sympathetic drive to various organs, and studies have shown preferential changes in cardiac SNA (CSNA) versus RSNA in heart failure and septic shock. [13] [14] [15] [16] Elevated CSNA levels promote adverse effects on the cardiovascular system. 17 In essential hypertensive patients, 6, 18 there is an increase in spillover of norepinephrine from the heart, which is correlated to cardiac hypertrophy. 19 The mechanisms that cause this increase in sympathetic outflow to the heart are not well understood. Understanding the reasons for the increase in cardiac spillover of norepinephrine is particularly relevant because it is the increase in CSNA that leads to arrhythmias and sudden death. 20 Moreover, an elevation in cardiac spillover of norepinephrine is associated with adverse prognosis in patients with heart failure. 21 A previous study has suggested that increases in spillover of norepinephrine from the heart may be driven by an impairment in norepinephrine uptake 22 ; however, it is neither known whether directly recorded CSNA is elevated in hypertension, nor how CSNA relates to (directly recorded) RSNA in hypertension.
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The arterial baroreflex has been shown to be an inhibitory reflex with control over the resting levels of sympathetic drive and heart rate. The baroreflex control of RSNA may be potentiated in the early phase of renovascular (2 kidney-1 clip [2K1C]) hypertension, 23 yet others suggest that RSNA baroreflex sensitivity is initially attenuated before recovering to near-normal levels. 24 In rabbits chronically infused with angiotensin II, the baroreflex control of RSNA was right shifted to higher pressure levels, but the sensitivity was unaltered. 25 In addition, it is not known whether the baroreflex control of CSNA is altered in hypertension.
Given that CSNA has never been directly recorded in an animal model of hypertension, we investigated whether hypertension was associated with an increase in directly recorded CSNA. A recent study has indicated that in patients with mild hypertension with no sign of organ damage, there is a significant reduction in renal conductance with no differences in nonrenal vascular conductance. 26 This implicates selective renal vasoconstriction in the pathogenesis of mild hypertension, and we consequently decided to directly record CSNA and RSNA in a renovascular large animal model of hypertension. We hypothesized that directly recorded CSNA levels would be elevated during renovascular hypertension and that baroreflex control of CSNA would be impaired during hypertension.
Methods
The data that support the findings of this study are available from the corresponding author on reasonable request. All experiments were approved by the Animal Ethics Committee of the University of Auckland (AEC#01332). Nonpregnant adult New Zealand ewes (weighing 40-70 kg) were housed in individual metabolic cages in association with other sheep. Humidity, room temperature (16°C), and automated light-dark cycle were kept constant. Sheep were fed daily, given water ad libitum, and food and water intake was monitored. The experimental protocol was not started until sheep had acclimatized to the new surroundings and human contact.
Surgical Procedures
Each animal underwent 2 aseptic surgical procedures before experimentation. General anesthesia was induced by intravenous thiopental sodium (15 mg/kg) and maintained by (2%-3%) isoflurane after intubation. Intraoperatively, sheep were treated with intramuscular antibiotics (20 mg/kg oxytetracycline).
In the first surgery, the renal artery was exposed and isolated through retroperitoneal incision, and a metal clip was tightened around the artery to reduce blood flow by ≈40%. In the second surgery 2 weeks later, up to 6 custom-made intrafascicular electrodes were obliquely inserted in the cardiac and renal sympathetic nerve, ensuring that the tip was positioned in the center of the nerve. Electrodes were then fixed in place with cyanoacrylate glue, the implantation site was covered with a layer of Kwik-Sil (Coherent Scientific, Hilton, Australia), and the wires were exteriorized next to the sutured wound. A metal wire was sutured in the skin as a ground. Note that renal sympathetic nerves were approached via retroperitoneal incision contralateral to the clipped kidney. The procedure for the cardiac surgery has been described. 27 After nerve electrode placement, in the same surgery, a solid-state blood pressure transducer (Millar Instruments, Auckland, New Zealand) was cannulated caudally in the carotid artery. Additionally, the jugular vein was cannulated for drug infusion.
Postsurgical analgesia was ensured by intravenous injection of ketoprofen (2 mg/kg) daily for 3 days. To minimize the effects of surgical stress, experiments were not started until 3 days after each surgery. On completion of the experimental protocol, animals were euthanized by overdose intravenous injection of sodium pentobarbital (≈300 mg/kg).
Experimental Procedures
Experiments were conducted on standing, conscious sheep. Baseline recordings were made at approximately the same time of day when sheep were observed to be quietly standing in their cages. Baroreflex curves were constructed from data collected during infusion of phenylephrine (Sigma-Aldrich, St Louis, MI) and sodium nitroprusside (Sigma-Aldrich) at escalating doses (0.02 up to 0.9 mg/min). To determine the role of the autonomic nervous system in mediating the hypertension, the arterial pressure and heart rate response to hexamethonium chloride (Sigma-Aldrich; 250 mg over 2 hours) was determined. To determine the role of the autonomic nervous system, the mean arterial pressure and heart rate response to the nonselective β-adrenergic receptor antagonist propranolol (30 mg bolus followed by 0.5 mg/kg per hour for 90 minutes) and atropine sulfate (8 mg bolus followed by 48 mg/hr infusion for 30 minutes) was determined in separate groups of normotensive (n=8 and 8) and hypertensive animals (n=7 and 6, respectively).
Data Analysis

Sympathetic Nerve and Hemodynamic Recordings
SNA was recorded and analyzed as described. 15 Briefly, CSNA and RSNA were recorded differentially between the pair of electrodes with the best signal-to-noise ratio. The signal was amplified (×100 000), filtered (band pass 300-1000 Hz), and passed through an audio amplifier and loud speaker. The raw signals of SNA (5000 Hz) and arterial pressure (100 Hz) were recorded using a CED Micro 1401 interface (Cambridge Electronic Design, Ltd, Cambridge, UK) and Spike2 data acquisition and analysis software v8.01 (Cambridge Electronic Design). Data were analyzed on a beat-to-beat basis using a customwritten script on the Spike2 software. The program determined heart period and diastolic, systolic, and mean arterial pressure for each heartbeat. SNA was quantified using 3 methods: spikes and burst probability as described 28 and raw voltages. For spikes, a threshold was carefully selected just above the background noise level taken during the highest dose of phenylephrine infusion when SNA bursts were completely suppressed. This background noise was subtracted from all data collected. Discriminated spikes were recorded when SNA exceeded the threshold. For burst probability, the SNA signal was rectified and integrated using a time constant of 20 ms. Background noise was subtracted from all data collected, and the remaining area under the curve for each heart beat was considered the size of a burst. A set of 10 of the smallest bursts were visually identified, and their integrated area was used to determine the minimal burst area. Bursts equal or greater to this were counted as bursts. The accuracy of burst determination was visually inspected for each sheep. Differences in contact between the electrode and the nerve can influence raw voltages, but we have also included raw voltages as a comparison.
Generation of Baroreflex Curves
Heartbeats were ordered according to either diastolic blood pressure (for SNA baroreflex curves) or systolic blood pressure (for heart rate baroreflex curves) and averaged in groups of 10. These points were used to draw baroreflex curves using a 4-parameter sigmoidal fit equation on SigmaPlot v13.0 (Systat Software, Chicago, IL): where y 0 = lower plateau, a=range of the baroreflex curve, b=gain of the baroreflex curve, x 0 =BP 50 of the curve, the blood pressure when heart rate or SNA is 50% of the maximum. The curves were scaled to the baseline level of SNA set at 100% and the lower plateau set at 0%. 29 In addition, the saturation and threshold levels were calculated, as described. 30 The quality of the SNA signal and resulting baroreflex curves was subjected to independent assessment by a separate researcher using a semiquantitative grading scale. Researchers were blinded to the animal's group. Relative burst amplitude was calculated by setting the largest burst in the file as 100%, as described. 31 
Statistical Analysis
Data were analyzed with Prism, version 7.00 (GraphPad Software, Inc, San Diego, CA). Categorical variables were visually inspected for normal distribution and were compared using 2-tailed Student t test or ANOVA, as appropriate. Values are presented as mean (±SEM). A 2-sided P value <0.05 was considered significant.
Results
Clipping-Induced Hypertension
Hypertension had established within 3 weeks of clipping (Figure 1; P<0.001 ). Ganglionic blockade with hexamethonium was associated with a significantly larger decrease in systolic pressure (−18±2 versus −10±2 mm Hg; P<0.05) and mean arterial pressure in hypertensive animals (n=8) compared with normotensive controls (n=10; Figure 1 ), indicating a greater contribution of the autonomic nervous system to the hypertension. There was no difference in the diastolic pressure response to ganglionic blockade between the groups. Baseline heart rate levels did not differ between the hypertensive and normotensive groups (Figure 1 ). There was no difference in the heart rate response to ganglionic blockade between the 2 groups (11±5 for the normotensive animals versus 22±8 bpm for the hypertensive animals; P=0.33). 
Baseline Levels of CSNA and RSNA
Nerve activity was recorded in 27 sheep: 6 had concomitant CSNA and RSNA, 11 had only RSNA, and 9 had only CSNA. Note that RSNA was measured contralateral to the clipped kidney. Recordings in the hypertensive group were made 21±5 days after clipping. Figure 2 shows representative samples of raw traces. In normal animals, the resting burst frequency (bursts/min) of CSNA was 25±9, which was significantly lower than the resting burst frequency of RSNA 93±8, consistent with previous studies.
15 Figure 3 shows that, in the hypertensive animals, CSNA burst frequency was increased by ≈50% (39±4 versus 25±9 bursts/min; P<0.05). In contrast, the resting levels of RSNA expressed as burst frequency was reduced by ≈25% compared with normotensive controls (69±20 versus 93±8 bursts/ min; P<0.005) suggesting a preferential increase in CSNA during this stage of hypertension. These differential changes remained consistent when the results were expressed as burst incidence (bursts/100 heart beats, Figure 3 ) or as spike incidence (CSNA increased from 3.5±0.6 to 6.6±1.3 spikes/ heartbeat; P<0.05, whereas RSNA decreased from 20.0±1.9 to 9.0±1.6 spikes/heartbeat; P<0.05). The baseline values of CSNA and RSNA expressed as raw voltages were more variable and showed a similar trend, although this was not significant (CSNA was 7.0±6.0 µV/s in normotensive animals and 12.0±10.0 µV/s in the hypertensive animals; RSNA was 76±94 µV/s in normotensive animals and 22±14 µV/s in the hypertensive animals).
Baroreflex Control of SNA and Heart Rate
Mean curves depicting the baroreflex control of heart rate in normal and hypertensive animals are shown in Figure 4 . Hypertension resulted in a rightward shift of the baroreflex curve (BP 50 120±13 versus 104±16 mm Hg; P=0.001). There was no change in the gain or the plateaus of the baroreflex control of heart rate ( Figure 4 ; Tables 1, 2) .
Differential regulation of baseline SNA in hypertensive versus normotensive animals was also observed in the baroreflex control of SNA. In hypertensive animals, the gain of the RSNA baroreflex curve was increased (−4.2±1.7% versus −7.9±3.7% ∆SNA/∆mm Hg; P<0.05), but this was not observed with CSNA (−4.5±1.8% versus −5.4±2.6% ∆SNA/∆mm Hg; P=0.44; Figure 5 ). In line with this, the maximum gain (gain at the BP 50 point) was significantly larger in hypertensives compared with normotensives for RSNA but not for CSNA (Tables 1, 2 ). These findings were consistent with results obtained with the area method (data not shown).
Response to Autonomic Nervous System Blockade
These blockade studies were done in a separate group of animals to the ones where SNA was recorded. Intravenous infusion of propranolol resulted in a decrease in heart rate in the hypertensive group (from 90±3 to 85±3 bpm; P<0.05) but no change in the normotensive group (from 85±5 to 83±4 bpm). There was no change in mean arterial pressure in either group of animals. Intravenous atropine increased mean heart rate in both groups of animals, but the increase in heart rate in the hypertensive animals was significantly larger than the normotensive animals (43±3 versus 31±3 bpm; P<0.05). 
Relative Burst Amplitude
Comparing raw nerve activity between animals is difficult given differences in size and contact between the nerve and the electrode. Previous studies have attempted to circumvent this by examining the size of sympathetic bursts as a percentage of the largest burst. We tested the hypothesis that the size of sympathetic bursts was different in hypertensive compared with normotensive animals by plotting the relative burst amplitude distribution with the largest burst set at 100%. No difference in burst size distribution could be discerned; the mean and median burst sizes were nearly identical ( Figure S1 in the online-only Data Supplement).
Discussion
This is the first time that CSNA has been directly recorded in any animal model of hypertension. We show that directly recorded CSNA is significantly elevated at this stage of renovascular hypertension, whereas sympathetic drive to the contralateral kidney (RSNA) is decreased. Contrary to our hypothesis, there was no change in baroreflex control of CSNA or heart rate in the hypertensive animals versus the normotensive controls. Our study demonstrates that CSNA and RSNA are differentially controlled in renovascular hypertensive compared with normotensive control sheep.
Increase in CSNA in Hypertension
Our finding that directly recorded cardiac sympathetic drive is increased in renovascular hypertension is consistent with studies in humans, indicating increased spillover of norepinephrine from the heart. 32 Our study would suggest that the increased spillover of norepinephrine is partly mediated by an increase in CSNA in addition to altered norepinephrine reuptake mechanisms. 22 This increased CSNA is maintaining the heart rate in this model because the decrease in heart rate is greater in the hypertensive group compared with the normotensive group after β-blockade. However, the elevated CSNA is not contributing to the increased mean arterial pressure given no change in mean arterial pressure when this activity is blocked. In this regard, the ganglionic blockade experiment suggests that the hypertension is neurogenic, but this cannot be mediated by the heart or the renal vascular bed. We hypothesize that SNA to the muscle or the mesenteric bed must be increased, but this remains untested.
Regarding the mechanisms of the elevated CSNA, angiotensin II signaling may be a culprit. 33 Previous studies have indicated that intracerebral infusion of angiotensin II in conscious sheep increased CSNA in normal sheep, 34 whereas central blockade of the type I receptor decreased CSNA in an animal model of heart failure. 35 In 2K1C rats, angiotensin type 1 receptor upregulation and increased oxidative stress were observed in brain stem areas controlling sympathetic output, 36, 37 further implicating angiotensin II in mediating the increase in CSNA. Moreover, a recent study showed that circulating aldosterone may be an important contributor to sympathoexcitation. 38 Circulating aldosterone may activate mineralocorticoid receptors in the brain, especially in the paraventricular nucleus, thereby increasing blood pressure and SNA. 39 Finally, we cannot rule out a role for increased afferent RSNA from the ischemic kidney. [40] [41] [42] [43] Rossi et al 44 have shown that after 6 weeks of renovascular hypertension, the increase in RSNA to the nonclipped kidney could be attenuated by denervation of the clipped kidney, suggesting that the renoreflex pathway could be responsible for the increase in RSNA. Anatomic and functional studies show that the renal afferents project to the paraventricular nucleus of the hypothalamus. 45, 46 It is known that cardiac afferents can alter RSNA, 47 but whether renal afferents also play a role in the increase in CSNA remains to be determined. 
RSNA Decrease
Our finding of reduced RSNA to the contralateral healthy kidney 3 weeks after clipping appears consistent with previous results obtained from hypertensive animal models mediated by high angiotensin II levels. In the 2K1C model of hypertension in the rabbit, RSNA seems to be initially (first 3 weeks) diminished 24 but elevated in a later phase of hypertension. 44, 48 Similarly, rats continuously infused with low-dose angiotensin II showed an initial drop of RSNA during the first 8 days. 49 In rabbits, however, RSNA increased markedly after 11 weeks. 25 Previous studies in rats 50 and rabbits 51 also indicate a reduction in RSNA 7 days into the hypertension. After a longer period of angiotensin II infusion or if additional stressor factors such as salt are added to the diet, sympathoexcitation to the kidney ensues. 52 In our sheep, we hypothesize that RSNA to the nonclipped kidney may become elevated after a more prolonged clipping period. Indeed, Rossi et al 44 have shown that after 6 weeks of renovascular hypertension, RSNA to the nonclipped kidney is significantly elevated compared with a sham group.
We speculate that there are multiple factors to explain the contralateral RSNA decrease.
Increases in circulating angiotensin II have been shown to lead to an increase in RSNA. 25 It is not clear whether there is a change in central levels of angiotensin II in this model, but a putative increase can lead to renal sympathoinhibition in sheep. 53 A state of fluid overload could also inhibit RSNA as has been shown experimentally 51, 54 ; however, whether the hypertensive animals in our study were in a state of volume overload was not determined in this study. Teleologically, renal sympathoinhibition from the clipped to the healthy kidney seems useful. 33 Although the pressor kidney is in a sodium-avid state because of intrarenal renin-angiotensin system activation, it seems that the healthy kidney reabsorbs less sodium to maintain fluid and electrolyte balance. Indeed, Blair-West et al 55 demonstrated cumulative sodium depletion after clipping in 2K1C sheep.
Another putative explanation for the reduction in RSNA is through the renoreflex pathway. 56 Renal afferent mechano-and chemosensitive nerves are primarily located in the renal pelvis, 57 and their activation exerts a negative feedback response to the renal efferents. 41 It has been suggested that afferent renal nerves are tonically active in natriuretic conditions. 56 Thus, afferent stimulation of the ischemic kidney could reduce RSNA to the contralateral kidney.
Sympathetic Contribution to Renovascular Hypertension
It is generally accepted that the initial stages of 2K1C hypertension are primarily renin mediated, 58, 59 whereas volume overload 58 and sympathoexcitation 60,61 play a more prominent role in the late phase. 62, 63 In 2K1C sheep, Blair-West et al report a surge in plasma renin and aldosterone levels days after clipping, which receded to near-normal levels after 1 week. 55 Importantly, their study showed that elevated circulating renin and aldosterone was not required for the persistence of hypertension. These results are consistent with a previous sheep study that indicated plasma levels of renin was strongly increased in the early phase (4 days) but had receded to mildly elevated levels in the late phase (22 days) after clipping. 64 Conversely, calculated total peripheral vascular resistance was significantly increased in the late compared with the early phase, suggesting increased sympathetic tone. These observations, together with our ganglionic blockade data, suggest that at the time of SNA recording 3 weeks after clipping, the initial renin-/aldosterone-dependent phase of hypertension had passed and was instead being primarily maintained by increased sympathoexcitatory drive.
Differential Response of SNA
It is well established that SNA is not uniform and can provide a regional tailored response to match stimuli and organ-specific demands in both physiological and pathological states. 4, 16, 65 There is extensive anatomical and physiological evidence supporting this organizational model of differential control of the sympathetic nervous system. 33, 66, 67 For example, volume expansion in conscious rabbits decreased RSNA but left lumbar SNA unchanged. 51 RSNA and CSNA have been simultaneously recorded in conscious sheep and consistently show differential responses in various settings. 13, 15, 68, 69 We show that renovascular hypertension is associated with a preferential activation of CSNA with a decrease in contralateral RSNA. Interestingly, such preferential activation of CSNA is also seen during heart failure. 13 We chose to analyze the data using spikes, burst frequency, and raw voltages. One advantage of using burst frequency is that this will primarily reflect efferent nerve activity. It must be mentioned that our recordings cannot distinguish between afferent and efferent nerves. However, given that a large portion of the activity recorded was baroreceptor entrained and abolished with phenylephrine, any contribution of afferent nerves will be minor in our preparation. The similarity in terms of conclusions drawn using burst frequency, voltages, or spikes supports our contention.
Perspectives
In conclusion, in this ovine model of 2K1C renovascular hypertension, we show that cardiac and contralateral RSNA were differentially controlled 3 weeks after clipping: baseline CSNA was increased, whereas RNSA to the nonclipped kidney was decreased. Our data indicate that the increase in cardiac spillover of norepinephrine observed in hypertensive patients is mediated by an increase in directly recorded CSNA. We speculate that the observed contralateral RSNA decrease is a homeostatic response to increased blood pressure and the sodium-avid state of the clipped kidney. Our data indicate that the differential early increase in CSNA during the progression of hypertension is similar to the early progression of CSNA during heart failure. Future studies will need to determine whether similar mechanisms are responsible for this early increase in CSNA.
